Every movement we make, whether walking, speaking or even breathing, depends on the health of our muscles and nerves. For people living with one of the more than 300 rare conditions known as ...
The Muscular Dystrophy Association (MDA) brought its Engage Community Seminar to Hershey, Pennsylvania, on July 18, uniting ...
New publication identifies neuromuscular junction transmission failure as a novel mechanism contributing to sarcopenia, with preclinical studies ...
Adeno-associated virus (AAV)–mediated gene therapy was one of the focal points of this year's Muscular Dystrophy Association conference. Here, Barry Byrne, MD, PhD, University of Florida, speaks to ...
Gene editing, AI, and platform technology offer significant opportunities in neuromuscular disease research despite systemic challenges. Robert Califf, MD, highlighted the need for multidisciplinary ...
THURSDAY, Oct. 23, 2025 (HealthDay News) — Autoimmune neuromuscular diseases may sound complex, but understanding them is the first step to getting the right care and support. Conditions such as ...
Cantor Fitzgerald has initiated Dyne Therapeutics (DYNE) at outperform, finding significant value in its FORCE platform to treat rare genetic muscle disease. Analyst Eric Schmidt said that the company ...
Spinal muscular atrophy (SMA) is a severe neurological disease for which there is presently no cure, although current therapies can alleviate symptoms. In the search for better treatment options, ...
Sad woman sitting in front of cabinet in the dark. In a retrospective analysis, researchers characterized the prevalence and outcomes of neuropsychiatric conditions among patients hospitalized with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results